UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Cutaneous manifestations of graft-versus-host disease (GVHD)

Author
Edward W Cowen, MD, MHSc
Section Editor
Jeffrey Callen, MD, FACP, FAAD
Deputy Editor
Abena O Ofori, MD

INTRODUCTION

Acute and chronic graft-versus-host disease (GVHD) are multisystem disorders that are complications of hematopoietic cell transplant (HCT). Skin involvement is common, and mucosal, hair, or nail abnormalities may also occur. Because these disorders share clinical and histopathological features with a variety of other skin diseases, thorough consideration of the differential diagnosis is essential for the management of post-HCT patients with lesions suggestive of cutaneous GVHD.

The clinical and histopathological features, differential diagnosis, and supportive therapy of cutaneous GVHD will be reviewed here. The epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention of acute and chronic GVHD are reviewed in greater detail separately. (See "Pathogenesis of graft-versus-host disease" and "Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease" and "Prevention of acute graft-versus-host disease" and "Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease" and "Treatment of chronic graft-versus-host disease".)

CLASSIFICATION

Classically, GVHD has been divided into acute and chronic forms based upon the time of onset of disease:

Acute GVHD – Manifestations of GVHD occurring within 100 days after HCT

Chronic GVHD – Manifestations of GVHD occurring more than 100 days after HCT

                         

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Fri May 20 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11:945.
  2. Peñas PF, Zaman S. Many faces of graft-versus-host disease. Australas J Dermatol 2010; 51:1.
  3. Goddard DS, Horn BN, McCalmont TH, Cordoro KM. Clinical update on graft-versus-host disease in children. Semin Cutan Med Surg 2010; 29:92.
  4. Vargas-Díez E, García-Díez A, Marín A, Fernández-Herrera J. Life-threatening graft-vs-host disease. Clin Dermatol 2005; 23:285.
  5. Friedman KJ, LeBoit PE, Farmer ER. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation. Arch Dermatol 1988; 124:688.
  6. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15:825.
  7. Imanguli MM, Alevizos I, Brown R, et al. Oral graft-versus-host disease. Oral Dis 2008; 14:396.
  8. Mays SR, Kunishige JH, Truong E, et al. Approach to the morbilliform eruption in the hematopoietic transplant patient. Semin Cutan Med Surg 2007; 26:155.
  9. Tsoi MS, Storb R, Jones E, et al. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-vs-host disease in man. J Immunol 1978; 120:1485.
  10. Weedon D. The lichenoid reaction pattern (interface dermatitis). In: Weedon's Skin Pathology, 3rd ed, Elsevier Limited, Edinburgh 2010. p.35.
  11. Lerner KG, Kao GF, Storb R, et al. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 1974; 6:367.
  12. Sharp MT, Horn TD. Graft-versus-host disease. In: Fitzpatrick's Dermatology in General Medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al. (Eds), McGraw-Hill, 2008. p.258.
  13. Kuykendall TD, Smoller BR. Lack of specificity in skin biopsy specimens to assess for acute graft-versus-host disease in initial 3 weeks after bone-marrow transplantation. J Am Acad Dermatol 2003; 49:1081.
  14. Zhou Y, Barnett MJ, Rivers JK. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation. Arch Dermatol 2000; 136:717.
  15. Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol 2006; 142:175.
  16. Drijkoningen M, De Wolf-Peeters C, Tricot G, et al. Drug-induced skin reactions and acute cutaneous graft-versus-host reaction: a comparative immunohistochemical study. Blut 1988; 56:69.
  17. Kohler S, Hendrickson MR, Chao NJ, Smoller BR. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am J Surg Pathol 1997; 21:988.
  18. Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev 2001; 53:357.
  19. Byun HJ, Yang JI, Kim BK, Cho KH. Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions. J Am Acad Dermatol 2011; 65:726.
  20. Marra DE, McKee PH, Nghiem P. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol 2004; 51:543.
  21. Patel AR, Turner ML, Baird K, et al. Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2009; 15:370.
  22. Yoshikawa T, Ihira M, Ohashi M, et al. Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28:77.
  23. Kitamura K, Asada H, Iida H, et al. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation. J Am Acad Dermatol 2008; 58:802.
  24. Horn TD, Redd JV, Karp JE, et al. Cutaneous eruptions of lymphocyte recovery. Arch Dermatol 1989; 125:1512.
  25. Bauer DJ, Hood AF, Horn TD. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery. Arch Dermatol 1993; 129:855.
  26. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27:893.
  27. Carreras E, Fernández-Avilés F, Silva L, et al. Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center. Bone Marrow Transplant 2010; 45:1417.
  28. Schaffer JV. The changing face of graft-versus-host disease. Semin Cutan Med Surg 2006; 25:190.
  29. Peñas PF, Jones-Caballero M, Aragüés M, et al. Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol 2002; 138:924.
  30. Inamoto Y, Storer BE, Petersdorf EW, et al. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood 2013; 121:5098.
  31. Skert C, Patriarca F, Sperotto A, et al. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica 2006; 91:258.
  32. Martires KJ, Baird K, Steinberg SM, et al. Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood 2011; 118:4250.
  33. Schaffer JV, McNiff JM, Seropian S, et al. Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol 2005; 53:591.
  34. Patel AR, Pavletic SZ, Turner ML, Cowen EW. The isomorphic response in morphealike chronic graft-vs-host disease. Arch Dermatol 2008; 144:1229.
  35. Martires KJ, Baird K, Citrin DE, et al. Localization of sclerotic-type chronic graft-vs-host disease to sites of skin injury: potential insight into the mechanism of isomorphic and isotopic responses. Arch Dermatol 2011; 147:1081.
  36. Creamer D, Martyn-Simmons CL, Osborne G, et al. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy. Arch Dermatol 2007; 143:1157.
  37. Goiriz R, Peñas PF, Delgado-Jiménez Y, et al. Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus. Lupus 2008; 17:591.
  38. Wei J, Zhang Y, Xu H, et al. Atopic dermatitis-like presentation of graft-versus-host disease: a novel form of chronic cutaneous graft-versus-host disease. J Am Acad Dermatol 2013; 69:34.
  39. Imanguli MM, Pavletic SZ, Guadagnini JP, et al. Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101:175.
  40. Shahrabi Farahani S, Treister NS, Khan Z, Woo SB. Oral verruciform xanthoma associated with chronic graft-versus-host disease: a report of five cases and a review of the literature. Head Neck Pathol 2011; 5:193.
  41. Zuo RC, Naik HB, Steinberg SM, et al. Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease. JAMA Dermatol 2015; 151:23.
  42. Shulman HM, Kleiner D, Lee SJ, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006; 12:31.
  43. Clark J, Yao L, Pavletic SZ, et al. Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease. Arch Dermatol 2009; 145:918.
  44. Oda K, Nakaseko C, Ozawa S, et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant 2009; 43:159.
  45. Jacobsohn DA, Kurland BF, Pidala J, et al. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. Blood 2012; 120:2545.
  46. Bassim CW, Fassil H, Mays JW, et al. Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures. Bone Marrow Transplant 2014; 49:116.
  47. Furlong T, Leisenring W, Storb R, et al. Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease. Biol Blood Marrow Transplant 2002; 8:206.
  48. Feldstein JV, Bolaños-Meade J, Anders VL, Abuav R. Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin. J Am Acad Dermatol 2011; 65:733.
  49. Marks C, Stadler M, Häusermann P, et al. German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. Br J Dermatol 2011; 165:18.
  50. Couriel D, Carpenter PA, Cutler C, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006; 12:375.
  51. Altman JS, Adler SS. Development of multiple cutaneous squamous cell carcinomas during PUVA treatment for chronic graft-versus-host disease. J Am Acad Dermatol 1994; 31:505.
  52. Brown SJ, Jackson GH, Reynolds NJ, Lawrence CM. Chronic cutaneous graft-versus-host disease associated with multiple cutaneous squamous cell carcinomas. Clin Exp Dermatol 2006; 31:472.
  53. Howe NR, Lang PG. Squamous cell carcinoma of the sole in a patient with chronic graft-vs-host disease. Arch Dermatol 1988; 124:1244.
  54. Demarosi F, Soligo D, Lodi G, et al. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100:63.
Topic Outline

GRAPHICS